Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Capital Expenditures (2016 - 2025)

China Pharma Holdings filings provide 16 years of Capital Expenditures readings, the most recent being $454.0 for Q4 2025.

  • On a quarterly basis, Capital Expenditures fell 97.68% to $454.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $59324.0, a 27.92% decrease, with the full-year FY2025 number at $59324.0, up 54.45% from a year prior.
  • Capital Expenditures hit $454.0 in Q4 2025 for China Pharma Holdings, down from $611.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $415977.0 in Q3 2021 to a low of -$55964.0 in Q1 2023.
  • Median Capital Expenditures over the past 5 years was $2959.0 (2022), compared with a mean of $56635.2.
  • Biggest five-year swings in Capital Expenditures: tumbled 4123.29% in 2023 and later surged 331.74% in 2024.
  • China Pharma Holdings' Capital Expenditures stood at $7056.0 in 2021, then tumbled by 486.45% to -$27268.0 in 2022, then surged by 116.6% to $4527.0 in 2023, then soared by 331.74% to $19545.0 in 2024, then crashed by 97.68% to $454.0 in 2025.
  • The last three reported values for Capital Expenditures were $454.0 (Q4 2025), $611.0 (Q3 2025), and -$65.0 (Q2 2025) per Business Quant data.